Suppr超能文献

p53和C-myc基因在肝癌及癌旁组织中的表达及其临床意义

Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.

作者信息

Niu Zhao-Shan, Li Bo-Kian, Wang Mei

机构信息

Department of Pathology, Medical College of Qingdao University, Qingdao 266021, Shandong Province, China.

出版信息

World J Gastroenterol. 2002 Oct;8(5):822-6. doi: 10.3748/wjg.v8.i5.822.

Abstract

AIM

To investigate the possible roles of p53 and C-myc genes in the primary hepatocellular carcinogenesis and the relationship between the liver hyperplastic nodule (LHN) and hepatocellular carcinoma(HCC).

METHODS

The expression of p53 and C-myc genes was detected immunohistochemically in 73 and 60 cases of HCC and pericarcinomatous tissues, respectively.

RESULTS

The positive expression of p53 in HCC was significantly higher than that in pericarcinomatous tissues (P<0.05). In pericarcinomatous tissues, the p53 expression was observed only in LHN, but not in liver cirrhosis (LC) and normal liver tissues. The positive expression rate of C-myc in HCC or LHN was significantly higher than that in LC or normal liver tissues (P<0.05 and P<0.01), however, no significant difference was found between HCC and LHN (P>0.05). The positive expression rate of p53 and C-myc in HCC was correlated with the histological differentiation, that in the poorly differentiated was significantly higher than that in well differentiated samples (P<0.05).

CONCLUSION

The overexpression of p53 and C-myc genes might play a role in the carcinogenesis of HCC; And LHN seems a preneoplastic lesion related to hepatocarcinogenesis; No evidence supports that LC contribute directly to the hepatocarcinogenesis.

摘要

目的

探讨p53和C-myc基因在原发性肝细胞癌发生中的可能作用以及肝增生结节(LHN)与肝细胞癌(HCC)之间的关系。

方法

分别采用免疫组织化学方法检测73例HCC及癌旁组织和60例HCC及癌旁组织中p53和C-myc基因的表达。

结果

HCC中p53的阳性表达显著高于癌旁组织(P<0.05)。在癌旁组织中,仅在LHN中观察到p53表达,而在肝硬化(LC)和正常肝组织中未观察到。HCC或LHN中C-myc的阳性表达率显著高于LC或正常肝组织(P<0.05和P<0.01),然而,HCC与LHN之间未发现显著差异(P>0.05)。HCC中p53和C-myc的阳性表达率与组织学分化相关,低分化样本中的阳性表达率显著高于高分化样本(P<0.05)。

结论

p53和C-myc基因的过表达可能在HCC的发生中起作用;并且LHN似乎是与肝癌发生相关的癌前病变;没有证据支持LC直接促成肝癌发生。

相似文献

3
Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.
World J Gastroenterol. 2005 Jul 28;11(28):4404-8. doi: 10.3748/wjg.v11.i28.4404.
8
Two-stage model of chemically induced hepatocellular carcinoma in mouse.
Oncol Res. 2013;20(11):517-28. doi: 10.3727/096504013X13747716581336.
10
[Immunohistochemical detection of p21ras, c-myc and p53 oncoproteins in hepatocellular carcinoma and in non-neoplastic liver tissue].
Arq Gastroenterol. 2004 Oct-Dec;41(4):225-8. doi: 10.1590/s0004-28032004000400005. Epub 2005 Mar 29.

引用本文的文献

1
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
2
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Theranostics. 2020 Jun 12;10(17):7527-7544. doi: 10.7150/thno.45989. eCollection 2020.
3
Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.
World J Gastroenterol. 2012 Jul 14;18(26):3458-64. doi: 10.3748/wjg.v18.i26.3458.
5
ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.
World J Gastroenterol. 2007 Dec 28;13(48):6581-7. doi: 10.3748/wjg.v13.i48.6581.
7
Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.
World J Gastroenterol. 2004 Feb 1;10(3):366-70. doi: 10.3748/wjg.v10.i3.366.
9
Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.
World J Gastroenterol. 2003 Jul;9(7):1571-5. doi: 10.3748/wjg.v9.i7.1571.
10
PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.
World J Gastroenterol. 2003 Jun;9(6):1220-6. doi: 10.3748/wjg.v9.i6.1220.

本文引用的文献

3
Gene expression patterns in human liver cancers.
Mol Biol Cell. 2002 Jun;13(6):1929-39. doi: 10.1091/mbc.02-02-0023.
5
The prognostic molecular markers in hepatocellular carcinoma.
World J Gastroenterol. 2002 Jun;8(3):385-92. doi: 10.3748/wjg.v8.i3.385.
7
[p53 gene mutation in hepatocellular carcinoma].
Zhonghua Wai Ke Za Zhi. 1998 Sep;36(9):531-2.
8
Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.
World J Gastroenterol. 2001 Aug;7(4):575-8. doi: 10.3748/wjg.v7.i4.575.
9
Hepatocellular carcinoma--cause, treatment and metastasis.
World J Gastroenterol. 2001 Aug;7(4):445-54. doi: 10.3748/wjg.v7.i4.445.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验